GlassScriptPhysician profile
Shawn Beck
NPI 1669661849
$7,722.26
in general payments reported to CMS, 2019-2025
48 companies · $1,101 in 2025
The $1,101 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,459 · 2020: $1,037 · 2021: $1,220 · 2022: $1,268 · 2023: $905 · 2024: $732 · 2025: $1,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,652 · Education: $85.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,652.28 |
| Education | $85.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $964.21 | 2019-2025 | Xtandi |
| Abbvie INC. | $893.77 | 2019-2025 | Lupron Depot, Botox |
| Procept Biorobotics Corporation | $725.37 | 2019-2025 | Aquabeam System, Aquabeam Robotic System |
| Janssen Biotech, INC. | $584.61 | 2019-2025 | Erleada, Akeega |
| Teleflex LLC | $412.25 | 2020-2025 | Urolift, Barrigel |
| Accord Healthcare, INC. | $388.92 | 2022-2025 | |
| Pfizer INC. | $387.83 | 2019-2025 | |
| Boston Scientific Corporation | $373.26 | 2019-2025 | Ams 700, Spaceoar System, Rezum Generator |
| Myovant Sciences INC. | $295.20 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $224.99 | 2019-2023 | |
| Urogen Pharma, INC. | $218.27 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $209.38 | 2021-2024 | Keytruda, Welireg, Lynparza |
| Laborie Medical Technologies Corp. | $209.12 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Blue Earth Diagnostics | $190.00 | 2021-2022 | |
| Coloplast Corp | $174.83 | 2019-2022 |
Show all 46 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$340,127.45 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.